by Scott Larrivee | Dec 3, 2024 | News
VALENCIA, Calif. – Dec. 3, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the creation of a Medical Radioisotopes Advisory Board. This panel of internationally recognized leaders in nuclear medicine will provide...
by Scott Larrivee | Nov 12, 2024 | News
VALENCIA, Calif. – November 12, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at William Blair’s Innovators Series: Radiopharmaceuticals virtual event on Thursday, November 14,...
by Scott Larrivee | Oct 29, 2024 | Blog, Utah
October 29, 2024 – Utah Business’ 2024 class of “Healthcare Heroes” includes one of Nusano’s very own, Greg Moffitt. Greg is the director of Target Development for Nusano. He operates at the forefront of efforts to addressing and solve the...
by Scott Larrivee | Oct 17, 2024 | News
Image above: Starget Pharma, stargetpharma.com VALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide...
by Scott Larrivee | Oct 7, 2024 | News
VALENCIA, Calif. – Oct. 7, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced it will speak at three industry conferences in October 2024. Oppenheimer 2nd Annual Targeted Radiopharmaceutical Therapies in...
